Victory Capital Management
IMDZ

Victory Capital Management’s Immune Design Corp. IMDZ Stock Holding History

Victory Capital Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-157,119
Closed -$613K – 1990
2017
Q4 		$613K Sell
157,119
-1,903,115
-92% -$10.4M ﹤0.01% 1302
2017
Q3 		$21.3M Buy
2,060,234
+82,670
+4% +$813K 0.05% 565
2017
Q2 		$19.3M Buy
1,977,564
+40,010
+2% +$281K 0.05% 585
2017
Q1 		$13.2M Buy
1,937,554
+202,149
+12% +$1.17M 0.03% 658
2016
Q4 		$9.54M Buy
1,735,405
+14,170
+0.8% +$100K 0.02% 683
2016
Q3 		$13M Buy
+1,721,235
New +$12.6M 0.04% 644

Other funds holding IMDZ

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Victory Capital Management's IMDZ Position: Q1 2018 in Review

Victory Capital Management sold out of Immune Design Corp. (IMDZ) in Q1 2018, closing a stake of 157,119 shares — an estimated $613K sold.

Victory Capital Management first reported a position in IMDZ in Q3 2016 and held it in 6 quarters. The position peaked at $21.3M in Q3 2017. 72 funds tracked by Wall St. Rank hold IMDZ as of Q1 2018.

  • Victory Capital Management reported no remaining Immune Design Corp. position as of Q1 2018 after selling out during the quarter.
  • Victory Capital Management sold 157,119 Immune Design Corp. shares in Q1 2018, an estimated $613K.
  • Victory Capital Management first reported a position in Immune Design Corp. in Q3 2016 and held it in 6 quarters.
  • Victory Capital Management's Immune Design Corp. position peaked at $21.3M in Q3 2017.
  • 72 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2018.

Based on Victory Capital Management's 13F filing for Q1 2018, filed 4 May 2018.